About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 34 record(s)
Req # A-2021-11668
Copies of the email chain between Michell Levine, Isabel Jaen Raasch, Tanya Potashnik, Douglas Clark, Guillaume Couillard, Riaz Awadia and Elena Lungu having the subject line "Call with IMC this morning", dated December 5, 2019.Organization: Patented Medicine Prices Review Board Canada
June 2021
Req # A-2021-03662
Copies of all documentation indicating how excessive revenue payments claimed from pharmaceutical companies were handled and how such payments are processed by the PMPRB.Organization: Patented Medicine Prices Review Board Canada
March 2021
Req # A-2020-18433
Copies of the daily calendar meetings, calls and other taskings for Melanie Bourassa-Forcier from June 1, 2019 to November 18, 2020.Organization: Patented Medicine Prices Review Board Canada
December 2020
Req # A-2020-18442
A detailed summary of all occasions the PMPRB has used the excessive price penalty for pharmaceutical companies, broken down by date, company penalized, the name of the drug in question, the amount penalized, and a summary of why the price was…Organization: Patented Medicine Prices Review Board Canada
December 2020